Echo Therapeutics to Report Trial Results of Symphony tCGM System at Critical Care Congress
Posted on January 22, 2013 at 07:51 AM EST
Echo Therapeutics, Inc. (Nasdaq: ECTE ), a company developing its needle-free Symphony^® Transdermal Continuous Glucose Monitoring (tCGM) System as a non-invasive, wireless, transdermal continuous glucose monitoring system, presented an expanded analysis of data collected from the clinical study of Echo's Symphony tCGM System in critically ill patients at Tufts Medical Center in Boston,